History, aetiology, and symptomatology of schizophrenia

Abstract Schizophrenia is a severe, chronic, often disabling mental illness with onset characteristically in early adulthood. This article reviews the historical concepts of schizophrenia by Kraepelin and Bleuler, and discusses recent developments in the aetiology of schizophrenia, with an emphasis on the interplay between biological, psychological, and social factors. Genetic factors play an important role in the aetiology, as they ‘programme’ the early development of the brain’s structure, including the neurotransmitter receptor systems. According to the stress–vulnerability model, environmental stress and high ‘expressed emotion’ can precipitate the onset as well as influence the course and outcome of the illness. Cannabis abuse has a significant impact on the risk of schizophrenia, particularly in individuals with biological vulnerability to develop the illness. Clinically, patients with schizophrenia present with symptoms comprising positive (first-rank) and negative symptoms.

[1]  R. Murray,et al.  Causal association between cannabis and psychosis: examination of the evidence , 2004, British Journal of Psychiatry.

[2]  T. Crow,et al.  The two-syndrome concept and neuroendocrinology of schizophrenia. , 1986, The Psychiatric clinics of North America.

[3]  A. Korten,et al.  Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study. , 1992, Psychological medicine. Monograph supplement.

[4]  N. Craddock,et al.  The beginning of the end for the Kraepelinian dichotomy , 2005, British Journal of Psychiatry.

[5]  N. Andreasen.  A unitary model of schizophrenia: Bleuler's "fragmented phrene" as schizencephaly. , 1999, Archives of general psychiatry.

[6]  P. Zandi,et al.  A review of the evidence from family, twin and adoption studies for a genetic contribution to adult psychiatric disorders , 2004, International review of psychiatry.

[7]  Sarah A. J. Reading,et al.  Neurobiology of Schizophrenia , 2006, Neuron.

[8]  James M. Stone,et al.  Review: Glutamate and dopamine dysregulation in schizophrenia — a synthesis and selective review , 2007, Journal of psychopharmacology.

[9]  H. Moore,et al.  Prefrontal DA Transmission at D1 Receptors and the Pathology of Schizophrenia , 2003, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[10]  Paul J. Harrison,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group. Genes for Schizophrenia? Recent Findings and Their Pathophysiological Implications , 2022 .

[11]  K H Nuechterlein,et al.  A heuristic vulnerability/stress model of schizophrenic episodes. , 1984, Schizophrenia bulletin.

[12]  Karl J. Friston,et al.  Patterns of Cerebral Blood Flow in Schizophrenia , 1992, British Journal of Psychiatry.

[13]  Michael F. Green,et al.  What are the functional consequences of neurocognitive deficits in schizophrenia? , 1996, The American journal of psychiatry.